Amar Ajmal

440 total citations
24 papers, 325 citations indexed

About

Amar Ajmal is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Amar Ajmal has authored 24 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Computational Theory and Mathematics. Recurrent topics in Amar Ajmal's work include Computational Drug Discovery Methods (8 papers), vaccines and immunoinformatics approaches (6 papers) and Synthesis and biological activity (5 papers). Amar Ajmal is often cited by papers focused on Computational Drug Discovery Methods (8 papers), vaccines and immunoinformatics approaches (6 papers) and Synthesis and biological activity (5 papers). Amar Ajmal collaborates with scholars based in Pakistan, Saudi Arabia and China. Amar Ajmal's co-authors include Abdul Wadood, Ashfaq Ur Rehman, Junjian Hu, Arif Mahmood, Ajmal Khan, Bader S. Alotaibi, Muhammad Umair, Ashraf N. Abdalla, Noor Rahman and Luca Rastrelli and has published in prestigious journals such as Scientific Reports, RSC Advances and International Journal of Biological Macromolecules.

In The Last Decade

Amar Ajmal

23 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amar Ajmal Pakistan	10	153	110	101	41	31	24	325
Abdul Rashid Issahaku South Africa	9	150 1.0×	112 1.0×	61 0.6×	25 0.6×	19 0.6×	36	304
Abdulrahim A. Alzain Sudan	13	218 1.4×	139 1.3×	119 1.2×	40 1.0×	65 2.1×	66	431
Leonardo Bruno Federico Brazil	11	117 0.8×	163 1.5×	104 1.0×	55 1.3×	41 1.3×	23	319
Hafiz Muzzammel Rehman Pakistan	13	198 1.3×	106 1.0×	111 1.1×	50 1.2×	49 1.6×	62	480
Ahmad Alzamami Saudi Arabia	12	158 1.0×	67 0.6×	83 0.8×	30 0.7×	14 0.5×	24	347
Xolani Henry Makhoba South Africa	7	149 1.0×	66 0.6×	62 0.6×	35 0.9×	18 0.6×	14	275
Kanipakam Hema India	13	170 1.1×	131 1.2×	55 0.5×	58 1.4×	77 2.5×	23	371
Aml Ghanem Egypt	10	213 1.4×	85 0.8×	107 1.1×	28 0.7×	30 1.0×	15	435
Francis E. Agamah South Africa	6	175 1.1×	126 1.1×	41 0.4×	39 1.0×	27 0.9×	12	340
Jaykant Vora India	12	155 1.0×	93 0.8×	62 0.6×	43 1.0×	40 1.3×	14	407

Countries citing papers authored by Amar Ajmal

Since Specialization

Citations

This map shows the geographic impact of Amar Ajmal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amar Ajmal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amar Ajmal more than expected).

Fields of papers citing papers by Amar Ajmal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amar Ajmal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amar Ajmal. The network helps show where Amar Ajmal may publish in the future.

Co-authorship network of co-authors of Amar Ajmal

This figure shows the co-authorship network connecting the top 25 collaborators of Amar Ajmal. A scholar is included among the top collaborators of Amar Ajmal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amar Ajmal. Amar Ajmal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taha, Muhammad, Fazal Rahim, Javed Khan, et al.. (2025). Design and synthesis of benzimidazole analogs as a potent inhibitor of acetylcholinesterase and butyrylcholinesterase and their docking and MD simulation analysis. Journal of Molecular Structure. 1348. 143407–143407. 1 indexed citations

Ahmad, Sohail, Abdulaziz Alouffi, Mashal M. Almutairi, et al.. (2025). Green synthesis of silver nanoparticles and characterization using Asparagus officinalis : Elucidation of Anti-diabetic potentials through In-Silico, In-Vitro, and In-Vivo Analyses. Green Chemistry Letters and Reviews. 18(1). 1 indexed citations

Taha, Muhammad, Fazal Rahim, Amar Ajmal, et al.. (2025). Synthesis and novel structural hybrid analogs of oxindole derivatives bearing piperidine ring, their antidiabetics II activity and molecular docking study. Journal of Molecular Structure. 1332. 141666–141666.

Nasır, Abdul, Abdus Samad, Amar Ajmal, et al.. (2024). Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations. International Journal of Biological Macromolecules. 272(Pt 1). 132855–132855. 3 indexed citations

Taha, Muhammad, Fazal Rahim, Sridevi Chigurupati, et al.. (2024). Synthesis of novel indazole derivatives as inhibitors of diabetics II along with molecular docking and simulation study. Journal of Molecular Structure. 1322. 140394–140394. 4 indexed citations

Chiou, Chien-Chun, Mashal M. Almutairi, Amar Ajmal, et al.. (2024). Targeting Yezo Virus Structural Proteins for Multi-Epitope Vaccine Design Using Immunoinformatics Approach. Viruses. 16(9). 1408–1408. 7 indexed citations

Ajmal, Amar, Mubarak A. Alamri, Asaad Khalid, et al.. (2024). Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug target. BMC Chemistry. 18(1). 57–57. 9 indexed citations

Abu‐Izneid, Tareq, Abdur Rauf, Saima Naz, et al.. (2024). In vivo biological screening of extract and bioactive compound from Ficus benghalensis L. and their in silico molecular docking analysis. Technology and Health Care. 32(6). 4019–4030. 1 indexed citations

Muhammad, Naveed, Abad Khan, Abdul Wadood, et al.. (2024). In vivo analgesic, anti-inflammatory and molecular docking studies of S-naproxen derivatives. Heliyon. 10(2). e24267–e24267. 4 indexed citations

10.

Ajmal, Amar, Muhammad Shahab, Muhammad Waqas, et al.. (2024). In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infections. Scientific Reports. 14(1). 13130–13130. 4 indexed citations

11.

Ajmal, Amar, et al.. (2024). In Silico Prediction of New Inhibitors for Kirsten Rat Sarcoma G12D Cancer Drug Target Using Machine Learning-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulation Approaches. Pharmaceuticals. 17(5). 551–551. 8 indexed citations

12.

Ullah, Hayat, Fazal Rahim, Imad Uddin, et al.. (2023). Synthesis, in vitro β-glucuronidase inhibitory potential and molecular docking study of benzimidazole analogues. Chemical Data Collections. 44. 100996–100996. 5 indexed citations

13.

Ajmal, Amar, Arif Mahmood, Mohammed Ageeli Hakami, et al.. (2023). Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus. Frontiers in Cellular and Infection Microbiology. 13. 1159389–1159389. 33 indexed citations

14.

Khan, Momin, Aftab Alam, Ajmal Khan, et al.. (2023). Synthesis of new bis(dimethylamino)benzophenone hydrazone for diabetic management: In-vitro and in-silico approach. Heliyon. 10(1). e23323–e23323. 31 indexed citations

15.

Samad, Abdus, Amar Ajmal, Arif Mahmood, et al.. (2023). Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation. Frontiers in Molecular Biosciences. 10. 1060076–1060076. 51 indexed citations

16.

Alotaibi, Bader S., Amar Ajmal, Mohammed Ageeli Hakami, et al.. (2023). New drug target identification in Vibrio vulnificus by subtractive genome analysis and their inhibitors through molecular docking and molecular dynamics simulations. Heliyon. 9(7). e17650–e17650. 19 indexed citations

17.

Ali, Hamid, Abdus Samad, Amar Ajmal, et al.. (2023). Identification of Drug Targets and Their Inhibitors in Yersinia pestis Strain 91001 through Subtractive Genomics, Machine Learning, and MD Simulation Approaches. Pharmaceuticals. 16(8). 1124–1124. 6 indexed citations

18.

Wadood, Abdul, Amar Ajmal, & Ashfaq Ur Rehman. (2022). Strategies for Targeting KRAS: A Challenging Drug Target. Current Pharmaceutical Design. 28(23). 1897–1901. 9 indexed citations

19.

Wadood, Abdul, Amar Ajmal, Muhammad Junaid, et al.. (2022). Machine Learning-based Virtual Screening for STAT3 Anticancer Drug Target. Current Pharmaceutical Design. 28(36). 3023–3032. 30 indexed citations

20.

Rahman, Noor, et al.. (2020). Core proteome mediated therapeutic target mining and multi-epitope vaccine design for Helicobacter pylori. Genomics. 112(5). 3473–3483. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact